Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Short-term Investments (2017 - 2019)

Cogent Biosciences has reported Short-term Investments over the past 3 years, most recently at $8.0 million for Q1 2019.

  • Quarterly results put Short-term Investments at $8.0 million for Q1 2019, up 15878.0% from a year ago — trailing twelve months through Mar 2019 was $8.0 million (up 15878.0% YoY), and the annual figure for FY2018 was $22.9 million, up 30464.0%.
  • Short-term Investments for Q1 2019 was $8.0 million at Cogent Biosciences, down from $22.9 million in the prior quarter.
  • Over the last five years, Short-term Investments for COGT hit a ceiling of $47.7 million in Q2 2018 and a floor of $50000.0 in Q1 2018.
  • Median Short-term Investments over the past 3 years was $15.5 million (2018), compared with a mean of $19.4 million.
  • Biggest five-year swings in Short-term Investments: skyrocketed 30464.0% in 2018 and later soared 15878.0% in 2019.
  • Cogent Biosciences' Short-term Investments stood at $75000.0 in 2017, then skyrocketed by 30464.0% to $22.9 million in 2018, then plummeted by 65.15% to $8.0 million in 2019.
  • The last three reported values for Short-term Investments were $8.0 million (Q1 2019), $22.9 million (Q4 2018), and $37.8 million (Q3 2018) per Business Quant data.